Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Depreciation & Amortization (CF) (2020 - 2025)

Historic Depreciation & Amortization (CF) for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $204482.0.

  • KORU Medical Systems' Depreciation & Amortization (CF) fell 1023.03% to $204482.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $842780.0, marking a year-over-year decrease of 691.21%. This contributed to the annual value of $888473.0 for FY2024, which is 207.76% up from last year.
  • As of Q3 2025, KORU Medical Systems' Depreciation & Amortization (CF) stood at $204482.0, which was down 1023.03% from $209487.0 recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' Depreciation & Amortization (CF) registered a high of $231370.0 during Q1 2024, and its lowest value of $109252.0 during Q1 2022.
  • Over the past 5 years, KORU Medical Systems' median Depreciation & Amortization (CF) value was $209487.0 (recorded in 2025), while the average stood at $181076.6.
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first skyrocketed by 9506.92% in 2023, then tumbled by 1023.03% in 2025.
  • Quarter analysis of 5 years shows KORU Medical Systems' Depreciation & Amortization (CF) stood at $113308.0 in 2021, then surged by 65.62% to $187658.0 in 2022, then increased by 21.68% to $228340.0 in 2023, then fell by 7.4% to $211454.0 in 2024, then decreased by 3.3% to $204482.0 in 2025.
  • Its Depreciation & Amortization (CF) stands at $204482.0 for Q3 2025, versus $209487.0 for Q2 2025 and $217357.0 for Q1 2025.